With effect from November 16, 2023, the unit rights in AcouSort AB will be traded on First North Growth Market. Trading will continue up until and including November 27, 2023. Instrument: Unit rights Short name: ACOU UR Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021021482 Order book ID: 311268 Market Segment: First North STO Tick Size: MiFID II tick size table With effect from November 16, 2023, the paid subscription units in AcouSort AB will be traded on First North Growth Market. Trading will continue until further notice. Instrument: Paid subscription units Short name: ACOU BTU Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021021490 Order book ID: 311269 Market Segment: First North STO Tick Size: MiFID II tick size table For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com Nasdaq Stockholm AB
Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of AcouSort AB (576/23)
© 2023 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.12.23 | Nasdaq Stockholm AB: New equity right for trading, AcouSort TO2 (684/23) | At the request of AcouSort AB, AcouSort AB equity rights will be traded on
First North Growth Market as from December 21, 2023.
Security name: ACOU TO2
----------------------------
Short name:... ► Artikel lesen | |
| 19.12.23 | ACOUSORT: The board of directors resolves to repurchase warrants series 2020/2023 | ||
| 13.12.23 | Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTU) of AcouSort AB (659/23) | Trading in AcouSort AB paid subscription units (BTU) is to cease. The last
trading day is December 15, 2023.
Short name: ACOU BTU
---------------------------
ISIN code: SE0021021490
---------------------------
Orderbook... ► Artikel lesen | |
| 12.12.23 | AcouSort's rights issue is registered - conversion of BTU into shares and warrants | ||
| 11.12.23 | FDA approval paves the way for AcouSort's first OEM commercialization within critical care diagnostics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
